Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses

Preferable treatments for epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) with brain metastasis are elusive. The study intended to estimate the relative efficacy and safety of systemic therapies. Clinical trials about therapies for EGFR-mutant, brain-metastatic NSCL...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Aging (Albany NY)
Main Authors: Zhao, Binghao, Wang, Yuekun, Wang, Yaning, Chen, Wenlin, Zhou, Lizhou, Liu, Peng Hao, Kong, Ziren, Dai, Congxin, Wang, Yu, Ma, Wenbin
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals 2020
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7425486/
https://ncbi.nlm.nih.gov/pubmed/32669477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.103455
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares